HEALTH OPTIONS
09/06/20 -"Once the darling of COVID-19 lockdown times, the Health sector (ex Pharma) has gone into reverse now that the risk needle has moved by 180°. Sure enough for the contrarians in us, this opens up ..."
Pages
65
Language
English
Published on
09/06/20
You may also be interested by these reports :
21/03/24
No surprise: 2023 revenues were up by 5% yoy and EBITDA by 2.2%. The EBITDA margin of the Consumer Access segment was effectively 16% in 2023 vs ...
20/03/24
Following the presentation, in parallel to the preliminary 2023 results. of the 2024-26 plan excluding Netco (the fixed network infrastructure assets ...
18/03/24
DT’s share price had been going nowhere for six years between 2015 and 2021 (ranging between €13 and €16) but since the merger of T-Mobile US with ...
13/03/24
SES published FY 23 results with flat revenues at €2,030m along with adjusted EBITDA of €1,025m down by -7.3% YOY due to a sudden undisclosed ...